• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Intuniv guanfacine 2015-09-18 Takeda Pharmaceuticals International AG Ireland Branch
Zalviso sufentanil 2015-09-19 FGK Representative Service GmbH
Comirnaty COVID-19 mRNA vaccine (nucleoside-modified) 2020-12-22 BioNTech Manufacturing GmbH
Cyramza ramucirumab 2014-12-20 Eli Lilly Nederland B.V.
Zydelig idelalisib 2014-09-19 Gilead Sciences Ireland UC
Tyverb lapatinib 2008-06-11 Novartis Europharm Limited
Cometriq cabozantinib 2014-03-22 Ipsen Pharma
Febuxostat Mylan febuxostat 2017-06-16 Mylan Pharmaceuticals Limited
SomaKit TOC edotreotide 2016-12-09 Advanced Accelerator Applications
RoActemra tocilizumab 2009-01-16 Roche Registration GmbH
Rivastigmine Sandoz rivastigmine 2009-12-11 Sandoz GmbH
Humalog insulin lispro 1996-05-01 Eli Lilly Nederland B.V.
Gefitinib Mylan gefitinib 2018-09-28 Mylan S.A.S.
Tesavel sitagliptin 2008-01-11 Merck Sharp & Dohme B.V.
Januvia sitagliptin 2007-03-21 Merck Sharp and Dohme B.V
Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) aripiprazole 2015-07-01 Mylan S.A.S
Tamiflu oseltamivir 2002-06-21 Roche Registration GmbH
COVID-19 Vaccine Janssen COVID-19 vaccine (Ad26.COV2-S [recombinant]) 2021-03-12 Janssen-Cilag International NV
Minjuvi tafasitamab 2021-08-27 Incyte Biosciences Distribution B.V.
Vpriv velaglucerase alfa 2010-08-27 Shire Pharmaceuticals Ireland Ltd?